UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events

Beck, M; Hughes, D; Kampmann, C; Pintos-Morell, G; Ramaswami, U; West, ML; Giugliani, R; (2018) Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events. Molecular Genetics and Metabolism Reports , 14 pp. 31-35. 10.1016/j.ymgmr.2017.10.008. Green open access

[thumbnail of Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events.pdf]
Preview
Text
Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events.pdf - Published Version

Download (276kB) | Preview

Abstract

This is a retrospective analysis of Fabry Outcome Survey data from children/adults (n = 677) receiving agalsidase alfa enzyme replacement therapy for a median of 3 years, examining cerebrovascular, cardiac, and renal morbidity endpoints separately. Cardiac events occurred at younger ages than cerebrovascular or renal events, cerebrovascular events were more frequent in females than males, and males were more likely to experience cardiac and renal events at a younger age than females.

Type: Article
Title: Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.ymgmr.2017.10.008
Publisher version: http://doi.org/10.1016/j.ymgmr.2017.10.008
Language: English
Additional information: © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Keywords: Agalsidase alfa, ERT, enzyme replacement therapy, Enzyme replacement therapy, FOS, Fabry Outcome Survey, Fabry disease, LVH, left ventricular hypertrophy, Long-term effectiveness, NE, not estimable, eGFR, estimated glomerular filtration rate
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: https://discovery.ucl.ac.uk/id/eprint/10039771
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item